Gabelli Healthcare & WellnessRX Trust to Redeem Its Outstanding 5.76% Series A Cumulative Preferred Shares

RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & Wellness^RX Trust (NYSE:GRX) (the “Fund”) authorized the redemption of all outstanding 5.76% Series A Cumulative Preferred Shares (the “Series A Preferred”). The shares will be redeemed at $25.0520 per Series A Preferred (the “Redemption Price”), which consists of $25.00 per Series A Preferred (the liquidation preference) plus accumulated and unpaid dividends and distributions to the redemption date of April 9, 2020 (the “Redemption Date”).

As of the Redemption Date, the Series A Preferred will no longer be deemed outstanding, dividends will cease to accumulate and all the rights of the Series A Preferred shareholders with respect to the Series A Preferred will cease, except the right to receive the Redemption Price.

The Series A Preferred Shares, which trade on the New York Stock Exchange under the symbol “GRX Pr A”, are rated “A2” by Moody’s Investors Service and have an annual dividend rate of $1.44 per share. The Series A Preferred Shares were issued on August 20, 2010 at $25.00 per share and pay distributions quarterly.

Questions relating to, and requests for additional copies of, the notice of redemption and the related materials should be directed to the Fund at 800-GABELLI (800-422-3554) or [phone].

About The Gabelli Healthcare & Wellness^RX Trust

The Gabelli Healthcare & Wellness^RX Trust is a diversified, closed-end management investment company with $288 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (NYSE:GBL).

About GAMCO Investors

GAMCO Investors, Inc., through its subsidiaries, manages private advisory accounts (GAMCO Asset Management Inc.), mutual funds and closed-end funds (Gabelli Funds, LLC). As of December 31, 2019, GAMCO Investors had $36.5 billion in assets under management.

NYSE – GRX Pr A
CUSIP – 36246K202